Carmichael Hill & Associates’s Emeren Group SOL Stock Holding History

Carmichael Hill & Associates’s Portfolio SOL Stock Details SOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	867
2022 Q1	$0	Buy	+1	New	+$6	﹤0.01%	833

Other funds holding SOL

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Carmichael Hill & Associates's SOL Position: Q2 2022 in Review

Carmichael Hill & Associates sold out of Emeren Group (SOL) in Q2 2022, closing a stake of 1 share.

Carmichael Hill & Associates first reported a position in SOL in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 62 funds tracked by Wall St. Rank hold SOL as of Q2 2022.

Carmichael Hill & Associates reported no remaining Emeren Group position as of Q2 2022 after selling out during the quarter.
Carmichael Hill & Associates sold 1 Emeren Group share in Q2 2022.
Carmichael Hill & Associates first reported a position in Emeren Group in Q1 2022 and held it in 1 quarter.
Carmichael Hill & Associates's Emeren Group position peaked at $0 in Q1 2022.
62 funds tracked by Wall St. Rank held Emeren Group as of Q2 2022.

Based on Carmichael Hill & Associates's 13F filing for Q2 2022, filed 5 Aug 2022.